Professor Gregory Monteith
Professor

Gregory Monteith

Email: 
Phone: 
+61 7 334 61855

Background

Greg studies cellular signalling in disease and the identification of new drug targets. Greg leads the Calcium Signalling Therapeutics Team (CaSTT) in the School of Pharmacy at UQ.

His lab specializes in the development and application of genetically encoded calcium indicators for high-content imaging in live cells. His team focuses on integrating these technologies into high-throughput assays that are critical for drug discovery efforts targeting calcium-mediated signaling pathways. The group has developed and utilized high-content imaging platforms to investigate calcium signaling in various cell types. These platforms enable the team to conduct large-scale screenings and these have been instrumental in identifying novel therapeutic targets.

Greg has established a research program with research funding via NHMRC, ARC, Queensland Cancer Council, Society of Biomolecular Screening, Department of Defense (USA) and other grants and collaboration with Pharmaceutical companies. His interests are signal transduction in disease, calcium transporters as drug targets and biomolecular screening. His work has led to patents and projects towards commercialization for new therapies for cancer.

In 2006 he received a UQ Foundation research excellence award and in 2016 he received the UQ Research Higher Degree Supervision Excellence Award - video link. Greg has also recieved a Research Mentorship Award (HaBS, 2017) and an award for Excellence in Leadership (UQ, 2016).

Availability

Professor Gregory Monteith is:
Available for supervision

Fields of research

Biological Sciences Oncology and carcinogenesis Pharmacology and pharmaceutical sciences

Qualifications

  • Bachelor (Honours), University of Sydney
  • Doctor of Philosophy, University of Sydney

Research interests

  • calcium regulation in disease and cell signalling

    Our current projects are focussed on the study of a variety of calcium transporters in disease for the identification of novel drug targets. PhD and Post-doctoral opportunities may be available, contact - gregm@uq.edu.au and see the "available projects" link.

  • High throughput calcium assays for biomolecular screening and cancer research

    Our laboratory has the the first FLIPR-tetra system in Australia, allowing high throughput measurement of intracellular calcium in living cells.

Search Professor Gregory Monteith’s works on UQ eSpace

419 works between 1992 and 2024
All (419) Journal Article (138) Book Chapter (7) Conference Publication (273) Book (1)

281 - 300 of 419 works

2007

Conference Publication

NHERF2 is a PDZ scaffold for PMCA: Effect of muscarinic activation

Kruger, WA, Monteith, GR and Poronnik, P (2007). NHERF2 is a PDZ scaffold for PMCA: Effect of muscarinic activation. 32nd Congress of the Federation-of-European-Biochemical-Societies (FEBS), Vienna AUSTRIA, JUL 07-12, 2007.

NHERF2 is a PDZ scaffold for PMCA: Effect of muscarinic activation

2007

Conference Publication

Calcium transport in the mammary gland: A role for secretory pathway calcium ATPase 2 (SPCA2) in normal physiology and breast cancer

Faddy, H. M., Smart, C. E., Brown, M. A., Feng, M., Rao, R., Roberts-Thomson, S. J. and Monteith, G. R. (2007). Calcium transport in the mammary gland: A role for secretory pathway calcium ATPase 2 (SPCA2) in normal physiology and breast cancer. ComBio 2007, Sydney, 22-26 September 2007.

Calcium transport in the mammary gland: A role for secretory pathway calcium ATPase 2 (SPCA2) in normal physiology and breast cancer

2007

Conference Publication

Alterations in the transcription of TRPV6, TRPV5 and TRPC1 during the differentiation of HT29 colon cancer cells

Chowdhury, M. A., Aung, C. S., Monteith, G. R. and Roberts-Thomson, S. J. (2007). Alterations in the transcription of TRPV6, TRPV5 and TRPC1 during the differentiation of HT29 colon cancer cells. Joint meeting 10th Southeast Asian Western Pacific Regional Meeting of Pharmacologists (SEAWP-RMP ) and Annual Scientific Meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) with HBPRCA: Drug and Chemical Safety, Adelaide, South Australia, Australia, 2-6 December 2007. Victoria, Australia: ASCEPT.

Alterations in the transcription of TRPV6, TRPV5 and TRPC1 during the differentiation of HT29 colon cancer cells

2007

Conference Publication

Secretory pathway Ca2+_ATPase isoforms in mouse lactation and in human breast cancer

Roberts-Thomson, S. J., Faddy, H. M., Smart, C. E., Brown, M. A., Xu, R., Lee, G. Y., Kenny, P. A., Bissell, M. J., Feng, M., Rao, R. and Monteith, G. R. (2007). Secretory pathway Ca2+_ATPase isoforms in mouse lactation and in human breast cancer. Australian Breast Cancer Conference 2007, Bio 21 Institute, Melbourne, 19-20 November 2007.

Secretory pathway Ca2+_ATPase isoforms in mouse lactation and in human breast cancer

2007

Journal Article

Plasma membrane Ca2+-ATPase expression during colon cancer cell line differentiation

Aung, C. S., Kruger, W. A., Poronnik, P., Roberts-Thomson, S. J. and Monteith, G. R. (2007). Plasma membrane Ca2+-ATPase expression during colon cancer cell line differentiation. Biochemical And Biophysical Research Communications, 355 (4), 932-936. doi: 10.1016/j.bbrc.2007.02.050

Plasma membrane Ca2+-ATPase expression during colon cancer cell line differentiation

2007

Conference Publication

The plasma membrane calcium ATPase (PMCA) in colon cancer

Aung, C. S., Roberts-Thomson, S. J. and Monteith, G. R. (2007). The plasma membrane calcium ATPase (PMCA) in colon cancer. ComBio2007 Combined Conference Abstracts, Sydney, 22-26 September 2007.

The plasma membrane calcium ATPase (PMCA) in colon cancer

2007

Conference Publication

TRPV1 and TRPV6 are upregulated in breast cancer cell lines

McAndrew, D., Roberts-Thomson, S. J. and Monteith, G. R. (2007). TRPV1 and TRPV6 are upregulated in breast cancer cell lines. ComBio 2007, Sydney, Australia, 22-26 September, 2007. South Australia: Australian Society for Biochemistry and Molecular Biology.

TRPV1 and TRPV6 are upregulated in breast cancer cell lines

2007

Conference Publication

Modulation of PPARα and PPARβ by ethanol in human breast cancer cell lines

Gopisetty Venkata, Nagaraj, Cabot, Peter, Monteith, Greg and Roberts-Thomson, Sarah (2007). Modulation of PPARα and PPARβ by ethanol in human breast cancer cell lines. 98th Annual Meeting of the American Association for Cancer Research, Los Angeles, U.S., 14-18 April, 2007. Philadelphia, U.S.: American Association for Cancer Research.

Modulation of PPARα and PPARβ by ethanol in human breast cancer cell lines

2006

Journal Article

The neural cell adhesion molecule antibody blocks cold water swim stress-induced analgesia and cell adhesion between lymphocytes and cultured dorsal root ganglion neurons

Hua, S., Hermanussen, S., Tang, L., Monteith, G. R. and Cabot, P. J. (2006). The neural cell adhesion molecule antibody blocks cold water swim stress-induced analgesia and cell adhesion between lymphocytes and cultured dorsal root ganglion neurons. Anesthesia and Analgesia, 103 (6), 1558-1564. doi: 10.1213/01.ane.0000243410.61451.c1

The neural cell adhesion molecule antibody blocks cold water swim stress-induced analgesia and cell adhesion between lymphocytes and cultured dorsal root ganglion neurons

2006

Journal Article

The μ opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway

Vetter, Irina, Wyse, Bruce D., Monteith, Gregory R., Roberts-Thomson, Sarah J. and Cabot, Peter J. (2006). The μ opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway. Molecular Pain, 2 (22) 22, 1-16. doi: 10.1186/1744-8069-2-22

The μ opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway

2006

Journal Article

The Effects of pH on Beta-Endorphin and Morphine Inhibition of Calcium Transients in Dorsal Root Ganglion Neurons

Vetter, I., Kapitzke, D., Hermanussen, S., Monteith, G. R. and Cabot, P. J. (2006). The Effects of pH on Beta-Endorphin and Morphine Inhibition of Calcium Transients in Dorsal Root Ganglion Neurons. The Journal of Pain, 7 (7), 488-499. doi: 10.1016/j.jpain.2006.01.456

The Effects of pH on Beta-Endorphin and Morphine Inhibition of Calcium Transients in Dorsal Root Ganglion Neurons

2006

Journal Article

Peroxisome proliferator-activated receptor alpha expression is regulated by estrogen receptor alpha and modulates the response of MCF-7 cells to sodium butyrate

Faddy, H. M., Robinson, J. A., Lee, W. J., Holman, N. A., Monteith, G. R. and Roberts-Thomson, S. J. (2006). Peroxisome proliferator-activated receptor alpha expression is regulated by estrogen receptor alpha and modulates the response of MCF-7 cells to sodium butyrate. International Journal of Biochemistry & Cell Biology, 38 (2), 255-266. doi: 10.1016/j.biocel.2005.09.002

Peroxisome proliferator-activated receptor alpha expression is regulated by estrogen receptor alpha and modulates the response of MCF-7 cells to sodium butyrate

2006

Conference Publication

The effects of mono (2-ethylhexyl) phthalate, mono-n-butyl phthalate and ethanol on PPARs in MCF-7 human breast cancer cells

Gopisetty Venkata, N., Robinson, J. A., Cabot, P. J., Monteith, G. R. and Roberts-Thomson, S. J. (2006). The effects of mono (2-ethylhexyl) phthalate, mono-n-butyl phthalate and ethanol on PPARs in MCF-7 human breast cancer cells. AACR 97th Annual Meeting 2006: Driving the science: From bench to bedside...and back, Washington, DC, U.S.A., 1-5 April, 2006. Philadelphia, PA, U.S.A.: American Association for Cancer.

The effects of mono (2-ethylhexyl) phthalate, mono-n-butyl phthalate and ethanol on PPARs in MCF-7 human breast cancer cells

2006

Conference Publication

Novel glyco-lipid-arsenicals(III) with anti-proliferative effects on MCF-7 human breast cancer cells

Wimmer, N, Robinson, JA, Gopisetty-Venkatta, N, Roberts-Thomson, SJ, Monteith, GR and Toth, I (2006). Novel glyco-lipid-arsenicals(III) with anti-proliferative effects on MCF-7 human breast cancer cells. 19th American Peptide Symposium, San Diego, CA, United States, June 18-23 2005. New York, N.Y., United States: Springer. doi: 10.1007/978-0-387-26575-9_148

Novel glyco-lipid-arsenicals(III) with anti-proliferative effects on MCF-7 human breast cancer cells

2006

Conference Publication

Modulation of TRPV1-mediated capsaicin responses potentiated through PKC and camp-dependent PKA pathways by the Mu opioid receptor agonist morphine

Vetter, I., Wyse, B. D., Monteith, G. R., Roberts-Thomson, S. J. and Cabot, P. J. (2006). Modulation of TRPV1-mediated capsaicin responses potentiated through PKC and camp-dependent PKA pathways by the Mu opioid receptor agonist morphine. ComBio 2006, Brisbane Convention Centre, Brisbane, Australia, 24-28 September, 2006. Kent Town, South Australia: Australian Society for Biochemistry and Molecular Biology.

Modulation of TRPV1-mediated capsaicin responses potentiated through PKC and camp-dependent PKA pathways by the Mu opioid receptor agonist morphine

2006

Conference Publication

Norathyriol, the active metabolite of mangiferin, modulates PPAR activity and is a potential nutritional bioactive

Wilkinson, A. S., Lin, C. N., Dietzgen, R. G., Monteith, G. R., Shaw, P. N., Roberts-Thomson, S. J. and Gidley, M. (2006). Norathyriol, the active metabolite of mangiferin, modulates PPAR activity and is a potential nutritional bioactive. Annual Conference of the Australasian Pharmaceutical Science Association, Adelaide Hilton, Adelaide, South Australia, 3-5 December, 2006. Malvern,Vic, Australia: Australasian Pharmaceutical Science Association.

Norathyriol, the active metabolite of mangiferin, modulates PPAR activity and is a potential nutritional bioactive

2006

Conference Publication

Nutritional bioactives in tropical fruit

Wilkinson, A, Hewavitharana, A, Flanagan, B M, Dietzgen, R G, Monteith, G R, Shaw, P N, Roberts-Thomson, S J and Gidley, M (2006). Nutritional bioactives in tropical fruit. The 3rd Australian Health & Medical Research Congress, Melbourne Convention Centre, Melbourne, Australia, 26 November-1 December, 2006. Melbourne, Vic, Australia: National Health and Medical Research Council.

Nutritional bioactives in tropical fruit

2006

Conference Publication

The effects of ethanol on PPARS in MCF-7 human breast cancer cells

Gopisetty Venkata, N., Cabot, P. J., Monteith, G. R. and Roberts-Thomson, S. J. (2006). The effects of ethanol on PPARS in MCF-7 human breast cancer cells. ComBio 2006, Brisbane Convention Centre, Brisbane, Australia, 24-28 September, 2006. Kent Town, South Australia: Australian Society for Biochemistry and Molecular Biology.

The effects of ethanol on PPARS in MCF-7 human breast cancer cells

2006

Conference Publication

PRG100, a novel anti-allodynic agent

Tsui, D. Y. Y., Wyse, B. D., Monteith, G. R. and Smith, M. T. (2006). PRG100, a novel anti-allodynic agent. 26th Annual Scientific Meeting of the Australian Pain Society, Melbourne, Australia, 9-12 April, 2006. Victoria, Australia: Australian Pain Society.

PRG100, a novel anti-allodynic agent

2006

Conference Publication

A role for secretory pathway calcium atpase 2 (SPCA2) in calcium transport, breast cancer and mammary gland development

Faddy, H. M., Smart, C. E., Brown, M. A., Roberts-Thomson, S. J. and Monteith, G. R. (2006). A role for secretory pathway calcium atpase 2 (SPCA2) in calcium transport, breast cancer and mammary gland development. ComBio 2006, Brisbane / Brisbane Convention Centre, 24-28 September 2006. Kent Town, South Australia: Australian Society for Biochemistry and Molecular Biology.

A role for secretory pathway calcium atpase 2 (SPCA2) in calcium transport, breast cancer and mammary gland development

Current funding

  • 2025 - 2028
    A First-in-Class Calcium Channel Inhibitor for the Treatment of Advanced Metastatic Prostate Cancers Resistant to Next-Generation Antiandrogen Therapy
    United States Congressionally Directed Medical Research Programs - Prostate Cancer Research Program
    Open grant
  • 2023 - 2026
    A calcium influx pathway regulates adaptive cancer drug tolerance
    NHMRC IDEAS Grants
    Open grant

Past funding

  • 2023 - 2024
    A calcium influx pathway regulates adaptive cancer drug tolerance
    TdC Pioneering Grant
    Open grant
  • 2022 - 2025
    An active ion transport pathway exploited by coronaviruses
    ARC Discovery Projects
    Open grant
  • 2020 - 2024
    Deciphering and intercepting messages between cancer cells and cells in the breast cancer microenvironment: Roles for intracellular calcium signaling
    United States Congressionally Directed Medical Research Programs - Breast Cancer Research Program
    Open grant
  • 2020 - 2023
    A recently identified calcium channel provides diverse opportunities for pharmacotherapy in breast cancer
    NHMRC IDEAS Grants
    Open grant
  • 2019 - 2021
    Exploiting remodelling of calcium signalling to specifically target triple negative breast cancer via promotion of apoptosis
    Cancer Council Queensland
    Open grant
  • 2018 - 2024
    Australian Red Cross Blood Service Chair in Donor Behaviour
    Australian Red Cross Blood Service
    Open grant
  • 2018 - 2021
    Calcium cycling and heat generation in skeletal muscle fibres
    ARC Discovery Projects
    Open grant
  • 2018
    High-throughput ion channel pharmacology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2020
    Pharmacological targeting of an adaptive breast cancer cell survival pathway as a novel treatment for breast cancer: Constitutive Ca2+ influx mechanisms in triple negative breast cancer cells
    Cancer Council Queensland
    Open grant
  • 2017 - 2021
    Exploiting the Remodeling of Ca2+ Signaling in Breast Cancer Cell Microenvironments to Control Metastasis and to Specifically Target Brain Metastases
    United States Congressionally Directed Medical Research Programs - Breast Cancer Research Program
    Open grant
  • 2015 - 2021
    Collaborative Grants between WMHHS and University of Queensland
    West Moreton Hospital and Health Service
    Open grant
  • 2015 - 2017
    Exploiting the overexpression of a specific calcium permeable ion channel in breast cancer cells: a new pharmacological approach to targeting breast cancer.
    NHMRC Project Grant
    Open grant
  • 2015 - 2018
    Resistance to Herceptin (trastuzumab) in HER2 positive breast cancers: the role of calcium signalling
    NHMRC Project Grant
    Open grant
  • 2015
    The assessment of mitochondrial oxygen consumption and cytoplasmic glycolysis in cells to identify and characterize new therapeutic targets for diseases
    UQ Major Equipment and Infrastructure
    Open grant
  • 2014
    A medium-throughput cell isolation and analysis suite
    UQ Major Equipment and Infrastructure
    Open grant
  • 2013 - 2014
    QUE ORAI1 PROJECT
    Cancer Bequest Fund
    Open grant
  • 2013 - 2014
    Identification and characterisation of calcium signalling modifying proteins as drug targets for basal breast cancer
    Cancer Council Queensland
    Open grant
  • 2012 - 2015
    Calcium signaling and epithelial-mesenchymal transition: a new approach to identifying pharmacological targets for metastasis
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    The development of store operated calcium channel monoclonal antibody inhibitors as a therapeutic option for breast cancer treatment
    NHMRC Development Grant
    Open grant
  • 2011
    Establishment of a robotic liquid handling platofrm for the use of 384 and 1536 well plates
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010
    Cost effective acquisition of an LC-MS/MS system to support CIPDD organics analysis and preclinical and clinical operations
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010
    High content imaging analysis for bioactive and novel therapeutic target evaluation
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010 - 2013
    Two recently identified calcium transporters in lactation and during mammary epithelial cell apoptosis.
    NHMRC Project Grant
    Open grant
  • 2009 - 2011
    QUMmap and website
    Department of Health and Ageing (Commonwealth of Australia)
    Open grant
  • 2009 - 2010
    Multiphoton microscopy of living animals as a tool for immunology and cell biology studies
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2009
    A core pharmacy facility for molecular biology, expression and protein post translational modification studies in cancer, cardiovascular, pain and epilepsy research
    UQ School/Centre Co-Funding
    Open grant
  • 2009 - 2012
    Calcium Influx Pathways and Breast Cancer
    NHMRC Project Grant
    Open grant
  • 2009
    Robotics Instrumentation for High Throughput Sample preparation for Increased Productivity of the CIPDD/TetraQ's HPLC-MS/MS Systems for Quantitative Analysis of Organics in a Quality Systems NATA-Acc
    UQ Faculty Co-Funding
    Open grant
  • 2009 - 2011
    Secretory pathway calcium regulation and breast cancer
    Cancer Council Queensland
    Open grant
  • 2008 - 2011
    Nutritional properties of mango fruits: linking plant genomics to cellular bioactivities
    ARC Linkage Projects
    Open grant
  • 2008 - 2010
    Partnerships in Health Research Collaborative Challenge - Pick your Partners!
    Cancer Bequest Fund
    Open grant
  • 2008 - 2009
    QUMmap and Website June 2008
    Department of Health and Ageing (Commonwealth of Australia)
    Open grant
  • 2006 - 2007
    Calcium transporters and breast cancer: exploiting the link for new pharmaceutically relevant drug targets.
    UQ Foundation Research Excellence Awards - DVC(R) Funding
    Open grant
  • 2006 - 2008
    Maintenance and Promotion of the QUMMAP
    Department of Health and Ageing
    Open grant
  • 2005 - 2008
    Identification of nutritional bioactives in tropical fruit
    ARC Linkage Projects
    Open grant
  • 2005
    Establishment of an improved model of relapsing MS and the characterisation of the role of Peroxisome Proliferator - activated receoptors alpha and beta
    Multiple Sclerosis Research Australia
    Open grant
  • 2005
    Ethanol, PPARb and Breast Cancer
    Australian Brewers' Foundation
    Open grant
  • 2005
    NHMRC_Equipment Grant = DSI Telemetry System
    NHMRC Equipment Grant
    Open grant
  • 2005
    Uncharacterized Calcium Transporters as Targets for Disease: Training of a Pharmacy Student in Drug Target Identification and Characterization
    Pharmaceutical Society of Australia
    Open grant
  • 2004 - 2005
    NHMRC_Equipment Grant_HLTH_Pharmacy
    NHMRC Equipment Grant
    Open grant
  • 2004
    PPARb In Breast Cancer: Gene Transcription And Molecular Mechanisms
    University of Queensland Research Development Grants Scheme
    Open grant
  • 2004
    Role Of Plasma Membrane Ca Pump In High Glucose Induced Changes In Ca Signalling
    University of Queensland Research Development Grants Scheme
    Open grant
  • 2003 - 2004
    Assessment of Ca2+ levels in subcellular organelles and the activity of Ca2+ efflux pathways using fluorescence didgital imaging techniques: Application to high throughput screening
    Society for Biomolecular Screening
    Open grant
  • 2003
    Development of high-throughput assays for the identification of novel anticancer agents.
    Pharmaceutical Society of Australia
    Open grant
  • 2003
    Malvern Zetasizer 3000HS
    NHMRC Equipment Grant
    Open grant
  • 2003
    Unprecedented Alkaloid Hybrids that Selectively Modulate Various Cancers and the Central Nervous System
    University of Queensland Research Development Grants Scheme
    Open grant
  • 2002 - 2003
    The Maintenance and promotion of the quality use of medicines mapping project website.
    Department of Health and Ageing
    Open grant
  • 2002
    Funding for molecular biology computer software
    Brain Research Fund
    Open grant
  • 2002 - 2003
    Pharmacological investigation of the toxicological effects of high doses of systemic morphine
    Queensland Cancer Fund
    Open grant
  • 2002 - 2003
    The plasma membrane calcium ATPase (PMCA) in breast tumorigenic cells
    Queensland Cancer Fund
    Open grant
  • 2001 - 2002
    NHMRC Equipment Grant 2000
    NHMRC Equipment Grant
    Open grant
  • 2001
    A biohazard laminar flow hood for neuronal cell cultures:partial cost recovery from emergency purchase
    Brain Research Fund
    Open grant
  • 2001
    Partial funding to purchase a Biohazard II laminar flow hood.
    Pharmaceutical Society of Australia
    Open grant
  • 2001
    The plasma membrane Ca2+-ATPase (PMCA) in human mammary gland tumorigenesis
    Cancer Bequest Fund
    Open grant
  • 2000 - 2001
    Characterisation of peroxisome proliferator-activated receptors (PPARs) in neurons: are PPARs regulators of neuronal survival with roles in dementia and Alzheimer's disease.
    RL Cooper Medical Research Foundation Limited
    Open grant
  • 2000 - 2002
    The plasmalemmal calcium pump and vascular smooth muscle cell proliferation
    NHMRC Project Grant
    Open grant
  • 2000
    The regulation of mitochondrial calcium in tumorigenic and non-tumorigenic breast epithelial cells
    Pharmaceutical Society of Australia
    Open grant
  • 2000
    What are the consequences of plasma membrane calcium pump inhibition? implications for calcium homeostasis, proliferation and apoptosis.
    ARC Australian Research Council (Small grants)
    Open grant
  • 1999
    Expression of plasma membrane calcium pump isoforms in vascular smooth muscle cells
    ARC Australian Research Council (Small grants)
    Open grant
  • 1999
    Expression of the plasma membrane calcium pump during hypoxia and ischemia
    Pharmaceutical Society of Australia
    Open grant
  • 1999
    PPAR and neurotoxicity
    Brain Research Fund
    Open grant
  • 1999 - 2001
    The plasma membrane calcium pump as a target for inhibition by tyrosine kinase phosphorylation: implications for cardiovascular disease
    National Heart Foundation of Australia
    Open grant
  • 1999
    The use of fluorescence microscopy to investigate the role of the calcium pump in disease and the mechanism of excitatory side effects by high dose morphine
    Ramaciotti Foundation
    Open grant
  • 1999
    Travel costs to neurosciences meeting 1999
    Potter Foundation
    Open grant
  • 1998
    Regulation of calcium pumps in smooth muscle
    Pharmaceutical Society of Australia
    Open grant

Availability

Professor Gregory Monteith is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Calcium signalling pathways in cancer progression

  • Calcium signalling changes associated with viral infection

  • Calcium channels and pumps as drug targets

  • Design of innovative high throughput methods for drug screening and testing

Supervision history

Current supervision

  • Doctor Philosophy

    A Recently Identified Calcium Channel Provides Diverse Opportunities for Pharmacotherapy in Breast Cancer

    Associate Advisor

    Other advisors: Dr Ben Ross

  • Doctor Philosophy

    The intersection between calcium signaling pathways and coronavirus infection

    Associate Advisor

    Other advisors: Dr Larisa Labzin, Dr Melanie Robitaille

  • Doctor Philosophy

    Development of a new approach to target exosomes for cancer treatment

    Associate Advisor

    Other advisors: Dr Sherry Wu

Completed supervision

Enquiries

For media enquiries about Professor Gregory Monteith's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au